News
Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Syria’s interim President Ahmad al-Sharaa urged Sunni Muslim Bedouin tribes Saturday to “fully commit” to a ceasefire aimed at ending clashes with Druze-linked militias that left hundreds ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results